首页> 外国专利> IMMUNOASSAY FOR DETERMINING THE FREE TARGET (ANTIGEN) IN SAMPLES, AGAINST WHICH A THERAPEUTIC ANTIBODY IS DIRECTED (FREE TARGET IMMUNOASSAY)

IMMUNOASSAY FOR DETERMINING THE FREE TARGET (ANTIGEN) IN SAMPLES, AGAINST WHICH A THERAPEUTIC ANTIBODY IS DIRECTED (FREE TARGET IMMUNOASSAY)

机译:用于测定样本中游离靶标(抗原)的免疫测定法(免费靶标免疫测定法)

摘要

The objective of the invention is to improve the monitoring of therapeutic antibodies in the treatment of serious illnesses (asthma, rheumatism, tumors). The aim of the invention is to find a determination method by means of which the free target (antigen) of a therapeutic antibody can be determined, regardless of the recovery immunoassay. A sandwich immunoassay is constructed, by means of which only the free target protein that was not bound by the therapeutic antibody directed against said target is determined (free target immunoassay). Areas of application of the invention are medical diagnostics, therapy control, and pharmacological research.
机译:本发明的目的是改善对严重疾病(哮喘,风湿病,肿瘤)的治疗性抗体的监测。发明内容本发明的目的是找到一种确定方法,通过该方法可以确定治疗性抗体的游离靶标(抗原),而与回收免疫测定法无关。构建了夹心免疫测定法,通过该夹心免疫测定法,仅测定了未与针对所述靶标的治疗性抗体结合的游离靶标蛋白质(游离靶标免疫测定法)。本发明的应用领域是医学诊断,治疗控制和药理研究。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号